Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
M2CBD Formula is a proprietary, patent-pending nutraceutical formulation developed by Cannabotech. It combines cannabidiol (CBD) with a blend of functional mushroom extracts, including Lion's Mane (*Hericium erinaceus*), Shiitake (*Lentinula edodes*), and Reishi (*Ganoderma lucidum*). The formulation is specifically designed to enhance the bioavailability of CBD, with the company claiming a three-fold improvement in absorption compared to standard CBD products. Marketed as a consumer wellness supplement rather than a pharmaceutical drug, it is intended for general wellness support and is typically administered orally as drops or capsules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on M2CBD Formula.